Leading experts at Rutgers and Tel Aviv Universities hosted a symposium centered on the coronavirus pandemic and the research, response and lessons learned through the COVID-19 outbreak in the sister states of New Jersey and Israel. The virtual event was the first in a monthly series of joint scientific symposia and a broader research-based collaboration between the two universities.
A novel base editing technology invented at Rutgers, with the potential to be used for the creation of new cell and gene therapies, will be made available to researchers worldwide through an exclusive partnership with the Horizon Discovery Group.
Rutgers University signs two agreements with Santhera Pharmaceuticals to advance pioneering research for the treatment of congenital muscular dystrophy. The agreements complement ongoing research of Peter Yurchenco, professor at Rutgers Robert Wood Johnson Medical School and a pioneer in a novel gene therapy approach for the treatment of LAMA2-deficient congenital muscular dystrophy.
While many have been terrified by an invisible enemy, a group of drivers have known for sure that they are transporting and carrying the deadly coronavirus to the hands of Rutgers healthcare heroes with plastic face shields and white gowns.
Rutgers University and professional services company Accenture join efforts to solve the necessity of face shields and other personal protection equipment for healthcare workers and researchers on the front lines of the COVID-19 pandemic.
Rutgers University’s Office of Advanced Research Computing (OARC) is joining the Renaissance Computing Institute of the University of North Carolina at Chapel Hill and other partners to create a platform for testing novel internet architectures that could enable a faster, more secure internet.